NexImmune, Inc. Quarterly Debt-to-equity in % from Q3 2021 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
NexImmune, Inc. quarterly Debt-to-equity history and growth rate from Q3 2021 to Q2 2024.
  • NexImmune, Inc. Debt-to-equity for the quarter ending June 30, 2024 was 147 %, a 417% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 147 +119 +417% Jun 30, 2024
Q1 2024 75.8 +52.2 +221% Mar 31, 2024
Q4 2023 47.7 +29 +156% Dec 31, 2023
Q3 2023 37.8 +24.2 +178% Sep 30, 2023
Q2 2023 28.4 +17.9 +169% Jun 30, 2023
Q1 2023 23.6 +15.8 +203% Mar 31, 2023
Q4 2022 18.6 +12.3 +192% Dec 31, 2022
Q3 2022 13.6 -4.28 -24% Sep 30, 2022
Q2 2022 10.6 Jun 30, 2022
Q1 2022 7.78 Mar 31, 2022
Q4 2021 6.39 Dec 31, 2021
Q3 2021 17.9 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.